四环医药涨超4% 旗下聚乳酸面部填充剂“童颜针”获批上市

智通财经
Yesterday

四环医药(00460)涨超4%,截至发稿,涨4.55%,报0.69港元,成交额2688.74万港元。消息面上,四环医药公布,集团旗下渼颜空间生物科技(吉林)有限公司自主研发的聚乳酸面部填充剂(该产品)正式获得国家药品监督管理局批准的第三类医疗器械注册证,用以纠正中重度鼻唇沟皱纹。据悉,聚乳酸面部填充剂,市场简称“童颜针”,以左旋聚乳酸(PLLA)微球为核心成分,具有稳定的生物降解特性,可刺激自体...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10